Headlines
- Troy Asset Management's Position in Johnson & Johnson
- Recent Changes in Institutional Holdings of JNJ
- Institutional Ownership of Johnson & Johnson
Troy Asset Management Ltd has adjusted its position in Johnson & Johnson (NYSE:JNJ), reducing its holdings by 7.6% in the third quarter, as per its latest SEC filing. The firm now owns approximately 188,000 shares of the healthcare giant, with the total value of this stake at around $30.5 million. Despite this reduction, Johnson & Johnson remains one of Troy Asset Management's notable holdings, comprising about 1% of its investment portfolio.
In addition to Troy Asset Management's adjustments, other institutional investors have made changes to their positions in the company. In the second quarter, Innealta Capital LLC acquired a new position in Johnson & Johnson. Similarly, Highline Wealth Partners LLC also established a new stake in the third quarter. Notably, Mowery & Schoenfeld Wealth Management LLC increased its holdings in the same quarter, boosting its position by 58.7%. Morton Brown Family Wealth LLC made a significant increase, raising its holdings by 400%, while MFA Wealth Advisors LLC initiated a new investment in the second quarter.
Institutional investors continue to play a substantial role in Johnson & Johnson’s stock, as evidenced by the fact that they collectively own more than 69% of the company's shares. This broad institutional backing underscores the confidence in the company's long-term stability and growth prospects.
The ongoing adjustments in institutional ownership reflect an evolving landscape of investors refining their positions in one of the leading healthcare firms globally. Investors are keeping a keen eye on these changes, which may impact the company's future performance and its role within the broader healthcare sector.